EP2922876
IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.11.2013EP published:
10.10.2018EP application number:
13856357.2
EPO information:
European Patent Register
Max expiry date:
19.11.2033
Title:
IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
Timeline
Today
20.11.2013EP application
10.10.2018EP Publication
Owner
Name:
Mederis Diabetes, LLCAddress:
7515 Guinevere Drive, 77479, Sugar Land, Texas, US
Inventor
Name:
NESTOR, John, J.Address:
Sugar Land, Texas,, US
Priority
Number:
201261728649 PDate:
20.11.2012Country:
US
Classification
Categories:
C07K 19/00, A61K 38/16, A61P 3/10